NKTX Nkarta, Inc. - Common Stock

NASDAQ · Biotechnology · View on SEC EDGAR ↗
$2.53
Price · Aug 19, 2026
Fundamentals as of Aug 10, 2026

NKTX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$2.53
Market Cap
$180M
P/E (TTM)
-1.8
EPS (TTM)
$-1.41
Revenue (TTM)
$0
Div Yield
ROE
-31.1%
Debt/Equity
52W Range
$2 – $4

NKTX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $0
4-point trend, -100.0%
2019-12-31 2025-12-31
EPS $-1.41
5-point trend, +46.2%
2021-12-31 2025-12-31
Free Cash Flow $-90M
6-point trend, -76.2%
2020-12-31 2025-12-31
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
NKTX
Peer Median
P/E (TTM)
5-point trend, +77.6%
-1.8
1.2
P/B
5-point trend, -79.1%
0.6
1.2
Price / FCF
5-point trend, +78.9%
-2.0

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
NKTX
Peer Median
ROA
5-point trend, +18.3%
-23.0%
-58.9%
ROE
5-point trend, +6.0%
-31.1%
-79.0%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
NKTX
Peer Median
Current Ratio
5-point trend, -33.2%
12.7
5.4
Quick Ratio
5-point trend, -32.5%
12.4

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
NKTX
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
NKTX
Peer Median
EPS (Diluted)
5-point trend, +46.2%
$-1.41

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
NKTX
Peer Median

NKTX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 12 analysts
  • Strong Buy 4 33.3%
  • Buy 7 58.3%
  • Hold 1 8.3%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

6 analysts · 2026-08-15
Median target $11.00 +334.4%
Mean target $11.00 +334.4%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
-0.00%
Period EPS Actual EPS Est Surprise
June 30, 2026 $-0.54 $-0.38 -0.16%
March 31, 2026 $-0.37 $-0.38 0.01%
Dec. 31, 2025 $-0.37 $-0.32 -0.05%
Sept. 30, 2025 $-0.29 $-0.32 0.03%
June 30, 2025 $-0.31 $-0.36 0.05%
March 31, 2025 $-0.43 $-0.45 0.02%
Dec. 31, 2024 $-0.35 $-0.42 0.07%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
NKTX $131M -1.3 -31.1%
CUE $29M -1.1 195.8% -96.9% -119.3%
VYGR $232M -1.9 -49.5% -296.5% -54.4%
CHRS $172M 1.0 59.8% 398.4% 185.8%
OKUR -0.7 -1733.7% -88.6%
CRBU $151M -1.0 11.7% -1327.4% -102.8%
CNTB $159M -2.8 -99.8% -86687.5% -97.9%
TNYA $154M -1.2 -81.2%
CNTN $112M -2.7 -18.0%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 13
Annual Income Statement data for NKTX
Metric Trend 2025202420232022202120202019
Revenue 4-point trend, -100.0% $0 $0 · · $0 · $115.0K
R&D Expense 7-point trend, +425.2% $90M $97M $97M $91M $63M $36M $17M
SG&A Expense 7-point trend, +501.6% $32M $31M $35M $28M $23M $15M $5M
Operating Expenses 7-point trend, +443.1% $122M $128M $132M $119M $86M $52M $22M
Operating Income 7-point trend, -445.9% $-122M $-128M $-132M $-119M $-86M $-52M $-22M
Other Non-op 7-point trend, +13338.9% $2M $87.0K $42.0K $-470.0K $-16.0K $-3.0K $18.0K
Income Tax Flat — no change across 7 periods $0 $0 $0 $0 $0 $0 $0
Net Income 7-point trend, -393.9% $-104M $-109M $-118M $-114M $-86M $-91M $-21M
EPS (Basic) 5-point trend, +46.2% $-1.41 $-1.60 $-2.40 $-2.61 $-2.62 · ·
EPS (Diluted) 5-point trend, +46.2% $-1.41 $-1.60 $-2.40 $-2.61 $-2.62 · ·
Shares (Basic) 5-point trend, +125.2% 73,991,197 67,865,323 49,014,300 43,631,722 32,856,883 · ·
Shares (Diluted) 5-point trend, +125.2% 73,991,197 67,865,323 49,014,300 43,631,722 32,856,883 · ·
EBITDA 6-point trend, -122.4% $-113M $-119M $-126M $-116M $-85M $-51M ·
Balance Sheet 22
Annual Balance Sheet data for NKTX
Metric Trend 2025202420232022202120202019
Cash & Equivalents 7-point trend, +92.3% $40M $28M $31M $37M $61M $97M $21M
Short-term Investments 7-point trend, +1344.4% $237M $239M $217M $315M $177M $218M $16M
Prepaid Expense 7-point trend, +1215.0% $6M $6M $5M $9M $8M $4M $474.0K
Other Current Assets 7-point trend, +3503.0% $2M $3M $2M $3M $3M $1M $67.0K
Current Assets 7-point trend, +654.1% $283M $273M $253M $361M $246M $319M $37M
PP&E (Net) 7-point trend, +2066.3% $67M $75M $79M $62M $13M $9M $3M
PP&E (Gross) 7-point trend, +2468.4% $96M $96M $91M $68M $16M $11M $4M
Accum. Depreciation 7-point trend, +4388.5% $29M $21M $12M $6M $3M $1M $645.0K
Other Non-current Assets 7-point trend, +273.0% $2M $4M $4M $2M $1M $547.0K $455.0K
Total Assets 7-point trend, +734.9% $404M $501M $379M $473M $274M $338M $48M
Accounts Payable 7-point trend, +11.0% $2M $638.0K $4M $2M $1M $1M $2M
Accrued Liabilities 7-point trend, +304.0% $13M $12M $14M $16M $9M $6M $3M
Current Liabilities 7-point trend, +172.7% $22M $19M $23M $22M $13M $9M $8M
Capital Leases 7-point trend, +1103.0% $70M $74M $82M $79M $10M $8M $6M
Other Non-current Liabilities 5-point trend, -35.1% $87.0K $87.0K · · $18.0K $82.0K $134.0K
Total Liabilities 7-point trend, +552.6% $92M $93M $106M $101M $23M $16M $14M
Common Stock 7-point trend, +600.0% $7.0K $7.0K $5.0K $5.0K $3.0K $3.0K $1.0K
Retained Earnings 7-point trend, -2331.8% $-648M $-544M $-435M $-318M $-204M $-118M $-27M
AOCI 7-point trend, +20450.0% $407.0K $674.0K $8.0K $-679.0K $-150.0K $3.0K $-2.0K
Stockholders' Equity 7-point trend, +1325.7% $312M $408M $273M $372M $251M $321M $-25M
Liabilities + Equity 7-point trend, +734.9% $404M $501M $379M $473M $274M $338M $48M
Shares Outstanding 7-point trend, +4340.7% 71,078,531 70,645,139 49,181,295 48,877,806 32,971,107 32,627,963 1,600,601
Cash Flow 10
Annual Cash Flow data for NKTX
Metric Trend 2025202420232022202120202019
D&A 7-point trend, +2200.0% $9M $9M $6M $3M $2M $800.0K $400.0K
Stock-based Comp 7-point trend, +803.8% $9M $17M $17M $17M $14M $7M $947.0K
Restructuring $5M · · · · · ·
Other Non-cash 6-point trend, -105.9% $-2M $-17M $8M $37M $2M $40M ·
Operating Cash Flow 7-point trend, -382.9% $-89M $-100M $-86M $-57M $-68M $-44M $-18M
CapEx 7-point trend, -37.3% $1M $4M $28M $47M $5M $8M $2M
Investing Cash Flow 7-point trend, +648.3% $100M $-130M $79M $-185M $33M $-210M $-18M
Financing Cash Flow 7-point trend, -99.7% $141.0K $226M $691.0K $219M $1M $330M $50M
Net Change in Cash 7-point trend, -9.0% $12M $-3M $-6M $-23M $-34M $76M $13M
Free Cash Flow 6-point trend, -76.2% $-90M $-104M $-114M $-104M $-73M $-51M ·
Profitability 2
Annual Profitability data for NKTX
Metric Trend 2025202420232022202120202019
ROA 6-point trend, +51.4% -23.0% -24.7% -27.6% -30.5% -28.1% -47.3% ·
ROE 6-point trend, -11.6% -31.1% -25.9% -41.2% -29.5% -33.0% -27.9% ·
Liquidity & Solvency 2
Annual Liquidity & Solvency data for NKTX
Metric Trend 2025202420232022202120202019
Current Ratio 6-point trend, -64.9% 12.7 14.4 10.8 16.4 19.0 36.1 ·
Quick Ratio 6-point trend, -65.2% 12.4 14.1 10.6 16.0 18.4 35.7 ·
Efficiency 1
Annual Efficiency data for NKTX
Metric Trend 2025202420232022202120202019
Asset Turnover Flat — no change across 3 periods 0.0 0.0 · · 0.0 · ·
Per Share 6
Annual Per Share data for NKTX
Metric Trend 2025202420232022202120202019
Book Value / Share 6-point trend, -55.4% $4.39 $5.78 $5.56 $7.62 $7.61 $9.84 ·
Revenue / Share Flat — no change across 2 periods $0.00 $0.00 · · · · ·
Cash Flow / Share 4-point trend, +8.2% $-1.20 $-1.47 $-1.76 $-1.31 · · ·
Cash / Share 6-point trend, -81.2% $0.56 $0.39 $0.63 $0.77 $1.84 $2.96 ·
Dividend / Share Flat — no change across 3 periods $0 $0 $0 · · · ·
EPS (TTM) 5-point trend, +46.2% $-1.41 $-1.60 $-2.40 $-2.61 $-2.62 · ·
Valuation (TTM) 9
Annual Valuation (TTM) data for NKTX
Metric Trend 2025202420232022202120202019
Revenue TTM Flat — no change across 3 periods $0 $0 · · $0 · ·
Net Income TTM 6-point trend, -13.9% $-104M $-109M $-118M $-114M $-86M $-91M ·
Market Cap 6-point trend, -93.4% $131M $176M $325M $293M $506M $2.01B ·
P/E 5-point trend, +77.6% -1.3 -1.6 -2.8 -2.3 -5.9 · ·
P/B 6-point trend, -93.3% 0.4 0.4 1.2 0.8 2.0 6.2 ·
P / Tangible Book 6-point trend, -93.3% 0.4 0.4 1.2 0.8 2.0 6.2 ·
P / Cash Flow 6-point trend, +96.8% -1.5 -1.8 -3.8 -5.1 -7.5 -46.1 ·
P / FCF 6-point trend, +96.3% -1.5 -1.7 -2.8 -2.8 -6.9 -39.3 ·
Earnings Yield 5-point trend, -346.5% -76.2% -64.3% -36.4% -43.6% -17.1% · ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $0$0$0
Net Income $-104M$-109M$-118M$-114M$-86M
Diluted EPS $-1.41$-1.60$-2.40$-2.61$-2.62
Balance Sheet
2025-12-312024-12-312023-12-312022-12-312021-12-31
Current Ratio 12.714.410.816.419.0
Quick Ratio 12.414.110.616.018.4
Cash Flow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Free Cash Flow $-90M$-104M$-114M$-104M$-73M

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 148 filers · $137.5M total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
32 (+14 vs prior Q) 13 (+4 vs prior Q) 46 (+2 vs prior Q) 34 (+6 vs prior Q) +943K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
RA CAPITAL MANAGEMENT, L.P. $30,578,515 10,805,129 22.24% Shares
NEA Management Company, LLC $10,099,650 3,568,781 7.35% Shares
SAMSARA BIOCAPITAL, LLC $9,926,695 3,507,666 7.22% Shares
SR One Capital Management, LP $9,433,332 3,333,333 6.86% Shares
GSK plc $8,916,572 3,150,732 6.48% Shares
Monaco Asset Management SAM $6,716,722 2,373,400 4.88% Shares
VANGUARD CAPITAL MANAGEMENT LLC $6,300,754 2,226,415 4.58% Shares
CITADEL ADVISORS LLC $6,154,528 2,174,745 4.48% Shares
TWO SIGMA INVESTMENTS, LP $5,301,419 1,873,293 3.86% Shares
STATE STREET CORP $3,639,688 1,286,109 2.65% Shares
RENAISSANCE TECHNOLOGIES LLC $3,332,755 1,177,652 2.42% Shares
WASATCH ADVISORS LP $3,329,257 1,577,847 2.42% Shares
GEODE CAPITAL MANAGEMENT, LLC $3,126,052 1,104,344 2.27% Shares
AWM Investment Company, Inc. $2,563,980 906,000 1.86% Shares
BlackRock, Inc. $2,220,384 784,588 1.61% Shares
Blackstone Inc. $2,114,135 747,044 1.54% Shares
PANAGORA ASSET MANAGEMENT INC $1,650,595 583,249 1.20% Shares
Peapod Lane Capital LLC $1,556,282 549,923 1.13% Shares
JPMORGAN CHASE & CO $1,548,938 543,487 1.13% Shares
Alyeska Investment Group, L.P. $1,372,097 484,840 1.00% Shares
TWO SIGMA ADVISERS, LP $1,197,320 647,200 0.87% Shares
DIMENSIONAL FUND ADVISORS LP $1,186,308 419,190 0.86% Shares
VANGUARD FIDUCIARY TRUST CO $985,366 348,186 0.72% Shares
MILLENNIUM MANAGEMENT LLC $915,955 323,659 0.67% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $854,422 301,916 0.62% Shares
XTX Topco Ltd $820,658 289,985 0.60% Shares
GOLDMAN SACHS GROUP INC $754,846 266,730 0.55% Shares
VANGUARD GROUP INC $604,970 327,011 0.44% Shares
IEQ CAPITAL, LLC $501,017 177,038 0.36% Shares
D. E. Shaw & Co., Inc. $415,574 146,846 0.30% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $370,659 130,975 0.27% Shares
NANO CAP NEW MILLENNIUM GROWTH FUND L P $367,900 130,000 0.27% Shares
FMR LLC $365,710 129,226 0.27% Shares
Susquehanna Portfolio Strategies, LLC $357,539 126,339 0.26% Shares
BRIDGEWAY CAPITAL MANAGEMENT, LLC $347,524 122,800 0.25% Shares
Qube Research & Technologies Ltd $341,889 120,809 0.25% Shares
BARCLAYS PLC $341,733 120,754 0.25% Shares
MACKENZIE FINANCIAL CORP $325,985 115,189 0.24% Shares
JANE STREET GROUP, LLC $315,899 111,625 0.23% Shares
Point72 Asset Management, L.P. $302,261 106,806 0.22% Shares
Man Group plc $283,133 100,047 0.21% Shares
AMERICAN CENTURY COMPANIES INC $268,428 94,851 0.20% Shares
JACOBS LEVY EQUITY MANAGEMENT, INC $233,922 82,658 0.17% Shares
CITADEL ADVISORS LLC $229,230 81,000 0.17% Call option
Mariner, LLC $222,169 78,504 0.16% Shares
ALLIANCEBERNSTEIN L.P. $213,005 100,950 0.15% Shares
Marquette Asset Management, LLC $212,451 75,071 0.15% Shares
Empowered Funds, LLC $197,087 69,642 0.14% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $188,886 66,744 0.14% Shares
HSBC HOLDINGS PLC $183,463 65,994 0.13% Shares
RHUMBLINE ADVISERS $171,129 60,473 0.12% Shares
Rangeley Capital, LLC $169,800 60,000 0.12% Shares
BANK OF AMERICA CORP /DE/ $161,250 56,979 0.12% Shares
PRELUDE CAPITAL MANAGEMENT, LLC $151,688 53,600 0.11% Shares
Verdad Advisers, LP $145,753 51,503 0.11% Shares
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC $142,985 48,143 0.10% Shares
LOS ANGELES CAPITAL MANAGEMENT LLC $115,656 40,868 0.08% Shares
Samalin Investment Counsel, LLC $115,323 40,750 0.08% Shares
Bank of New York Mellon Corp $109,954 38,853 0.08% Shares
WELLS FARGO & COMPANY/MN $105,950 37,438 0.08% Shares
Cerity Partners LLC $105,858 37,406 0.08% Shares
MERCER GLOBAL ADVISORS INC /ADV $95,445 33,726 0.07% Shares
CWM, LLC $89,954 42,632 0.07% Shares
Forefront Analytics, LLC $81,943 28,955 0.06% Shares
CANADA PENSION PLAN INVESTMENT BOARD $81,221 28,700 0.06% Shares
MARSHALL WACE, LLP $80,172 28,329 0.06% Shares
BANK OF MONTREAL /CAN/ $78,796 27,843 0.06% Shares
Cubist Systematic Strategies, LLC $71,083 34,340 0.05% Shares
Graham Capital Management, L.P. $67,858 23,978 0.05% Shares
Abel Hall, LLC $65,783 23,245 0.05% Shares
SIMPLEX TRADING, LLC $65,135 23,016 0.05% Shares
Nuveen, LLC $64,490 22,788 0.05% Shares
Creative Planning $62,232 21,990 0.05% Shares
Vanguard Personalized Indexing Management, LLC $59,605 21,062 0.04% Shares
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $58,253 20,584 0.04% Shares
Nuveen Asset Management, LLC $56,742 22,788 0.04% Shares
JANE STREET GROUP, LLC $56,600 20,000 0.04% Call option
CAPTRUST FINANCIAL ADVISORS $52,397 18,515 0.04% Shares
Vanguard Global Advisers, LLC $51,209 18,095 0.04% Shares
CITIGROUP INC $51,104 18,058 0.04% Shares
Invesco Ltd. $50,682 17,909 0.04% Shares
DIVERSIFIED TRUST CO $49,137 17,363 0.04% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $48,676 17,200 0.04% Put option
WINTON GROUP Ltd $44,714 15,800 0.03% Shares
BRIGHTON JONES LLC $41,746 14,751 0.03% Shares
Merit Financial Group, LLC $39,343 13,902 0.03% Shares
Focus Partners Wealth $36,620 12,940 0.03% Shares
INTECH INVESTMENT MANAGEMENT LLC $35,313 12,478 0.03% Shares
Arax Advisory Partners $34,130 12,060 0.02% Shares
Spark Investment Management LLC $33,111 11,700 0.02% Shares
Quadrature Capital Ltd $32,568 11,508 0.02% Shares
RAYMOND JAMES FINANCIAL INC $30,887 10,914 0.02% Shares
Pallas Capital Advisors LLC $30,708 10,851 0.02% Shares
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC $30,352 10,725 0.02% Shares
Police & Firemen's Retirement System of New Jersey $30,106 10,638 0.02% Shares
NEUBERGER BERMAN GROUP LLC $28,297 9,999 0.02% Shares
UBS Group AG $26,557 9,384 0.02% Shares
NEW YORK STATE COMMON RETIREMENT FUND $23,928 8,455 0.02% Shares
BNP PARIBAS FINANCIAL MARKETS $23,115 8,168 0.02% Shares
Tower Research Capital LLC (TRC) $22,665 8,009 0.02% Shares

Company insiders 27 insiders · 10 officers · 11 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Paul J Hastings Chief Executive Officer June 18, 2026 S 390,247 0 2 $-58,728
Matthew Plunkett Chief Financial Officer July 9, 2020 A 0 0 $0
Nadir Mahmood President Jan. 15, 2026 S 167,727 0 1 $-11,693
Shawn Marshall Rose Chief Medical Officer, Head of Research & Development Jan. 6, 2026 A 70,000 0 0 $0
Alyssa Levin Chief Financial and Business Officer Jan. 15, 2025 S 102,662 0 0 $0
David Shook Chief Medical Officer, Head of Research & Development Jan. 15, 2025 S 190,955 0 0 $0
Ralph Brandenberger Chief Technical Officer Jan. 15, 2025 S 124,796 0 0 $0
Alicia J. Hager Chief Legal Officer Jan. 15, 2025 S 146,735 0 0 $0
James Trager Chief Scientific Officer June 18, 2024 S 150,959 0 0 $0
Kanya Rajangam Chief Medical Officer Jan. 14, 2022 A 12,800 0 0 $0
George Vratsanos Director June 10, 2026 A 0 0 $0
Zachary Scheiner Director June 10, 2026 A 0 0 $0
Angela Thedinga Director June 10, 2026 A 0 0 $0
Ali Behbahani Director June 10, 2026 A 0 0 $0
Michael Dybbs Director June 10, 2026 A 0 0 $0
Simeon George Director June 10, 2026 A 451,659 0 0 $0
Leone D Patterson Director June 10, 2026 A 0 0 $0
Fouad Oscar Azzam Director June 7, 2023 A 0 0 $0
Tiba Aynechi Director June 8, 2022 A 0 0 $0
Laura Shawver Director June 8, 2022 A 0 0 $0
Mohamad Makhzoumi 10% owner July 14, 2020 C 2,902,115 0 0 $0
Anthony A. Florence, Jr. 10% owner July 14, 2020 C 2,902,115 0 0 $0
Peter W. Sonsini 10% owner July 14, 2020 C 2,902,115 0 0 $0
Novo Holdings A/S 10% owner July 14, 2020 C 2,793,865 0 0 $0
Forest Baskett 10% owner July 14, 2020 C 2,902,115 0 0 $0
Scott D. Sandell 10% owner July 14, 2020 C 2,902,115 0 0 $0
Joshua Makower 10% owner July 14, 2020 C 2,902,115 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 5 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
New Enterprise Associates 15, L.P., NEA Partners 15, L.P., NEA 15 GP, LLC, Forest Baskett, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell ×4 filings May 19, 2026 4.90% Amendment Passive investment SEC
Samsara BioCapital, L.P., Samsara BioCapital GP, LLC, Srinivas Akkaraju ×4 filings Nov. 24, 2025 4.90% Amendment SEC
LSP 6 Management B.V., LSP 6 Holding C.V., LSP 6 NK Holding B.V ×3 filings Feb. 12, 2025 4.00% Amendment SEC
RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×3 filings March 29, 2024 Initial filing SEC
Novo Holdings A/S ×4 filings June 3, 2022 Initial filing SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 23 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
OMFS · Invesco Exchange-Traded Self-Indexe… 0.07% 80,561 SH Aug. 8, 2026 Daily
IWC · iShares Trust 0.02% 150,315 SH Aug. 8, 2026 Daily
SFGV · EA Series Trust 0.02% 69,747 NS May 29, 2026 N-PORT
AVSC · AMERICAN CENTURY ETF TRUST 0.01% 90,267 NS May 31, 2026 N-PORT
VTWV · VANGUARD SCOTTSDALE FUNDS 0.01% 38,962 SH Aug. 8, 2026 Daily
PRFZ · Invesco Exchange-Traded Fund Trust 0.01% 103,003 SH Aug. 8, 2026 Daily
IWN · iShares Trust 0.01% 450,360 SH Aug. 8, 2026 Daily
ITWO · ProShares Trust 0.00% 2,199 NS May 31, 2026 N-PORT
RSSL · Global X Funds 0.00% 19,275 NS April 30, 2026 N-PORT
IWM · iShares Trust 0.00% 1,120,883 SH Aug. 8, 2026 Daily
DFAS · Dimensional ETF Trust 0.00% 137,619 NS April 30, 2026 N-PORT
UWM · ProShares Trust 0.00% 1,719 NS May 31, 2026 N-PORT
URTY · ProShares Trust 0.00% 1,737 NS May 31, 2026 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0.00% 1,985 NS May 31, 2026 N-PORT
HDG · ProShares Trust 0.00% 44 NS May 31, 2026 N-PORT
DCOR · Dimensional ETF Trust 0.00% 6,031 NS April 30, 2026 N-PORT
IWV · iShares Trust 0.00% 8,873 SH Aug. 8, 2026 Daily
AVUS · AMERICAN CENTURY ETF TRUST 0.00% 3,657 NS May 31, 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0.00% 599,527 SH Aug. 8, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 1,567,021 SH Aug. 8, 2026 Daily
VTWO · VANGUARD SCOTTSDALE FUNDS 0.00% 259,168 SH Aug. 8, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 3,786 SH Aug. 8, 2026 Daily
DFAC · Dimensional ETF Trust 0.00% 6,442 NS April 30, 2026 N-PORT